Disposition of intravenously administered adenosine 5'-phosphosulfate (APS) in rats. 1996

K Iwata, and K Matsuda, and Y Kurosaki, and T Nakayama, and H Nakajima, and T Kimura
Faculty of Pharmaceutical Sciences, Okayama University, Japan.

The disposition of adenosine 5'-phosphosulfate (APS), an endogenous nucleotide, was investigated in rats. The degradation of APS in rat plasma was very rapid. APS was degraded in rat plasma to AMP and ATP, and these nucleotides were further degraded through adenosine. The degradation kinetics was examined. For the in vivo study, the method to protect APS from degradation in blood was examined, and it was found that the addition of EDTA to APS-containing blood and storage at 4 degrees C can protect against APS degradation. After intravenous bolus injection, APS in plasma declined rapidly and the rate of elimination was dose-dependent: the biological half-life was about 2s at the dose of 0.3 mg/kg and was longer at 3 mg/kg. When APS was administered by intravenous infusion, the plasma level rapidly reached a steady-state, which then rapidly declined after the infusion was stopped. The total body clearance of APS could not be fully explained by metabolism in plasma or glomerular filtration, therefore the contribution of other elimination processes to the total body clearance was suggested.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000250 Adenosine Phosphosulfate 5'-Adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS. Adenylyl Sulfate,Adenosine 5'-Phosphosulfate,Phospho-Adenylsulfate,5'-Phosphosulfate, Adenosine,Adenosine 5' Phosphosulfate,Phospho Adenylsulfate,Phosphosulfate, Adenosine,Sulfate, Adenylyl
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

K Iwata, and K Matsuda, and Y Kurosaki, and T Nakayama, and H Nakajima, and T Kimura
August 1976, Analytical biochemistry,
K Iwata, and K Matsuda, and Y Kurosaki, and T Nakayama, and H Nakajima, and T Kimura
January 1999, Archives of biochemistry and biophysics,
K Iwata, and K Matsuda, and Y Kurosaki, and T Nakayama, and H Nakajima, and T Kimura
July 1971, Analytical biochemistry,
K Iwata, and K Matsuda, and Y Kurosaki, and T Nakayama, and H Nakajima, and T Kimura
January 1980, Zeitschrift fur Naturforschung. Section C, Biosciences,
K Iwata, and K Matsuda, and Y Kurosaki, and T Nakayama, and H Nakajima, and T Kimura
November 1981, Journal of biochemistry,
K Iwata, and K Matsuda, and Y Kurosaki, and T Nakayama, and H Nakajima, and T Kimura
August 2011, The Journal of biological chemistry,
K Iwata, and K Matsuda, and Y Kurosaki, and T Nakayama, and H Nakajima, and T Kimura
April 1977, Archives of microbiology,
K Iwata, and K Matsuda, and Y Kurosaki, and T Nakayama, and H Nakajima, and T Kimura
January 2000, The Journal of biological chemistry,
K Iwata, and K Matsuda, and Y Kurosaki, and T Nakayama, and H Nakajima, and T Kimura
April 2007, Journal of toxicology and environmental health. Part A,
K Iwata, and K Matsuda, and Y Kurosaki, and T Nakayama, and H Nakajima, and T Kimura
January 1982, Pharmaceutica acta Helvetiae,
Copied contents to your clipboard!